Mitochondrial-Targeted SS-31 Attenuates the Doxorubicin-Induced Cardiomyoblast H9C2 Cell Senescence.

This is a source-metadata record last found in a complete check on Sep 25, 2026. It is not a Pependium assessment of safety or effectiveness. Check the original sources for current details, corrections and full methods.

Source status: This saved record has not yet had a scheduled exact-ID status check. Check its original source links.

Study metadata

Study type: Original study
Study category (metadata hint): Cell or laboratory
Published: 2026-06-28
Authors: Fan J, Wu J, Yan S, Li S, Rabinovitch PS, Qi X, Zhang H.
Journal or registry: Not reported
Registry study design: Not reported
Registry enrollment: Not reported
Funding agencies: NIGMS NIH HHS; American Heart Association; U.S. National Science Foundation; NIA NIH HHS
Identifiers: DOI: 10.3390/biology15131034 · PMID: 42450582 · PMCID: PMC13359912
First found: Sep 25, 2026
Last found: Sep 25, 2026

Original sources

View at Europe PMC ↗